Global foot-and-mouth disease research update and gap analysis: 3 – Vaccines
This study assessed research knowledge gaps in the field of FMDV (foot-and-mouth disease virus) vaccines. The study took the form of a literature review (2011–15) combined with research updates collected in 2014 from 33 institutes from across the world. Findings were used to identify priority areas...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Journal Article |
| Lenguaje: | Inglés |
| Publicado: |
Hindawi Limited
2016
|
| Materias: | |
| Acceso en línea: | https://hdl.handle.net/10568/76166 |
| _version_ | 1855542300011134976 |
|---|---|
| author | Robinson, L. Knight-Jones, Theodore J.D. Charleston, B. Rodríguez, L.L. Gay, C.G. Sumption, Keith J. Vosloo, W. |
| author_browse | Charleston, B. Gay, C.G. Knight-Jones, Theodore J.D. Robinson, L. Rodríguez, L.L. Sumption, Keith J. Vosloo, W. |
| author_facet | Robinson, L. Knight-Jones, Theodore J.D. Charleston, B. Rodríguez, L.L. Gay, C.G. Sumption, Keith J. Vosloo, W. |
| author_sort | Robinson, L. |
| collection | Repository of Agricultural Research Outputs (CGSpace) |
| description | This study assessed research knowledge gaps in the field of FMDV (foot-and-mouth disease virus) vaccines. The study took the form of a literature review (2011–15) combined with research updates collected in 2014 from 33 institutes from across the world. Findings were used to identify priority areas for future FMD vaccine research. Vaccines play a vital role in FMD control, used both to limit the spread of the virus during epidemics in FMD-free countries and as the mainstay of disease management in endemic regions, particularly where sanitary controls are difficult to apply. Improvements in the performance or cost-effectiveness of FMD vaccines will allow more widespread and efficient disease control. FMD vaccines have changed little in recent decades, typically produced by inactivation of whole virus, the quantity and stability of the intact viral capsids in the final preparation being key for immunogenicity. However, these are exciting times and several promising novel FMD vaccine candidates have recently been developed. This includes the first FMD vaccine licensed for manufacture and use in the USA; this adenovirus-vectored FMD vaccine causes in vivo expression of viral capsids in vaccinated animals. Another promising vaccine candidate comprises stabilized empty FMDV capsids produced in vitro in a baculovirus expression system. Recombinant technologies are also being developed to improve otherwise conventionally produced inactivated vaccines, for example, by creating a chimeric vaccine virus to increase capsid stability and by inserting sequences into the vaccine virus for desired antigen expression. Other important areas of ongoing research include enhanced adjuvants, vaccine quality control procedures and predicting vaccine protection from immune correlates, thus reducing dependency on animal challenge studies. Globally, the degree of independent vaccine evaluation is highly variable, and this is essential for vaccine quality. Previously neglected, the importance of evaluating vaccination programme effectiveness and impact is increasingly being recognized. |
| format | Journal Article |
| id | CGSpace76166 |
| institution | CGIAR Consortium |
| language | Inglés |
| publishDate | 2016 |
| publishDateRange | 2016 |
| publishDateSort | 2016 |
| publisher | Hindawi Limited |
| publisherStr | Hindawi Limited |
| record_format | dspace |
| spelling | CGSpace761662025-01-06T09:43:39Z Global foot-and-mouth disease research update and gap analysis: 3 – Vaccines Robinson, L. Knight-Jones, Theodore J.D. Charleston, B. Rodríguez, L.L. Gay, C.G. Sumption, Keith J. Vosloo, W. animal diseases This study assessed research knowledge gaps in the field of FMDV (foot-and-mouth disease virus) vaccines. The study took the form of a literature review (2011–15) combined with research updates collected in 2014 from 33 institutes from across the world. Findings were used to identify priority areas for future FMD vaccine research. Vaccines play a vital role in FMD control, used both to limit the spread of the virus during epidemics in FMD-free countries and as the mainstay of disease management in endemic regions, particularly where sanitary controls are difficult to apply. Improvements in the performance or cost-effectiveness of FMD vaccines will allow more widespread and efficient disease control. FMD vaccines have changed little in recent decades, typically produced by inactivation of whole virus, the quantity and stability of the intact viral capsids in the final preparation being key for immunogenicity. However, these are exciting times and several promising novel FMD vaccine candidates have recently been developed. This includes the first FMD vaccine licensed for manufacture and use in the USA; this adenovirus-vectored FMD vaccine causes in vivo expression of viral capsids in vaccinated animals. Another promising vaccine candidate comprises stabilized empty FMDV capsids produced in vitro in a baculovirus expression system. Recombinant technologies are also being developed to improve otherwise conventionally produced inactivated vaccines, for example, by creating a chimeric vaccine virus to increase capsid stability and by inserting sequences into the vaccine virus for desired antigen expression. Other important areas of ongoing research include enhanced adjuvants, vaccine quality control procedures and predicting vaccine protection from immune correlates, thus reducing dependency on animal challenge studies. Globally, the degree of independent vaccine evaluation is highly variable, and this is essential for vaccine quality. Previously neglected, the importance of evaluating vaccination programme effectiveness and impact is increasingly being recognized. 2016-06 2016-07-13T04:28:00Z 2016-07-13T04:28:00Z Journal Article https://hdl.handle.net/10568/76166 en Open Access Hindawi Limited Robinson, L., Knight-Jones, T.J.D., Charleston, B., Rodriguez, L.L., Gay, C.G., Sumption, K.J. and Vosloo, W. 2016. Global foot-and-mouth disease research update and gap analysis: 3 – Vaccines. Transboundary and Emerging Diseases 63(Suppl. 1): 30–41. |
| spellingShingle | animal diseases Robinson, L. Knight-Jones, Theodore J.D. Charleston, B. Rodríguez, L.L. Gay, C.G. Sumption, Keith J. Vosloo, W. Global foot-and-mouth disease research update and gap analysis: 3 – Vaccines |
| title | Global foot-and-mouth disease research update and gap analysis: 3 – Vaccines |
| title_full | Global foot-and-mouth disease research update and gap analysis: 3 – Vaccines |
| title_fullStr | Global foot-and-mouth disease research update and gap analysis: 3 – Vaccines |
| title_full_unstemmed | Global foot-and-mouth disease research update and gap analysis: 3 – Vaccines |
| title_short | Global foot-and-mouth disease research update and gap analysis: 3 – Vaccines |
| title_sort | global foot and mouth disease research update and gap analysis 3 vaccines |
| topic | animal diseases |
| url | https://hdl.handle.net/10568/76166 |
| work_keys_str_mv | AT robinsonl globalfootandmouthdiseaseresearchupdateandgapanalysis3vaccines AT knightjonestheodorejd globalfootandmouthdiseaseresearchupdateandgapanalysis3vaccines AT charlestonb globalfootandmouthdiseaseresearchupdateandgapanalysis3vaccines AT rodriguezll globalfootandmouthdiseaseresearchupdateandgapanalysis3vaccines AT gaycg globalfootandmouthdiseaseresearchupdateandgapanalysis3vaccines AT sumptionkeithj globalfootandmouthdiseaseresearchupdateandgapanalysis3vaccines AT vosloow globalfootandmouthdiseaseresearchupdateandgapanalysis3vaccines |